Cases & Deals

Baxalta invests in OncoResponse

Clients Baxalta Inc.

Jones Day represented Baxalta Inc., a biopharmaceutical manufacturer headquartered in Northern Illinois, in connection with its purchase of Series A Convertible Preferred Stock in a private placement by OncoResponse, an immuno-oncology antibody discovery company.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.